Reviews

Ticker: 508869 FV: Rs.5
52-Week H/L: Rs.1262/911.10

We had recommended Apollo Hospitals in Volume No 34, Issue No 46 (dated Sept 3, 2018), when the scrip was trading at Rs 1191. Our recommendation was based on factors like robust growth in Q1FY19 and addition of new hospitals. Although the constant addition of new hospitals and aggressiveramp up is exerting pressure on margins, strong growth in the topline is expected in the upcoming quarters. However, the existing and new pharmacy stores are helping the company to maintain its overall EBITDA margins. The management expects 20 per cent growth in the segment in the near term. The company's extended capex plan is nearing completion, which will lead to reduced finance costs for the company. Also, it has acquired 50 per cent stake in Medics Super Speciality Hospital in Lucknow. Thus, we urge investors to HOLD the scrip.

INDIAN ENERGY EXCHANGE

Ticker: 540750 FV: Rs.1
52-Week H/L: Rs.177.10/140.50

We had recommended Indian Energy Exchange in Volume No 34, Issue No 48 (dated Sept 17, 2018), when the scrip was trading at Rs 1704. Our recommendation was based on factors like huge growth potential and strong financial performance. The management is optimistic of delivering double digit growth in the upcoming quarters. Constant volume growth with stable pricing is helping the company to grow further. Management is focusing on gaining share from licensed traders for boosting its volumes. Spot power trading at IEX touched 293 million units in September, making it the highest daily volume of electricity traded in the market till date. High temperatures in Delhi, Maharashtra and central India in October has led to higher demand for IEX. Thus, we urge investors to HOLD the scrip.